Aging microglia, often termed "senescent" or "primed" microglia, represent the cumulative effects of cellular aging on the brain's resident immune cells. With age, microglia undergo profound phenotypic changes including telomere shortening, mitochondrial dysfunction, DNA damage accumulation, and a shift toward a pro-inflammatory "inflammaging" phenotype[1][2]. These age-related changes profoundly impact brain function and are considered a major risk factor for neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD).
The aging brain shows increased microglial activation, elevated pro-inflammatory cytokine levels, and reduced capacity for inflammatory resolution. This chronic, low-grade neuroinflammation ("inflammaging") is now recognized as a key contributor to age-related cognitive decline and neurodegenerative disease progression[3].
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000129 | microglial cell |
Single-cell RNA sequencing has revealed distinct aging-associated microglial states[4][5]:
Hammond et al. (2019) - Mouse Lifespan Study:
Mrdjen et al. (2018) - Human Brain Mapping:
O'Korontinos et al. (2022) - Human Aging Cortex:
| Marker | Change | Function |
|---|---|---|
| P2RY12 | ↓ | Homeostatic function |
| TMEM119 | ↓ | Maturation marker |
| CX3CR1 | ↓ | Neuronal signaling |
| APOE | ↑ | Lipid metabolism |
| TYROBP | ↑ | Signaling adaptor |
| LYZ2 | ↑ | Antimicrobial |
| CST3 | ↑ | Protease inhibitor |
| IFN-response genes | ↑ | Type I interferon |
Aging microglia exhibit multiple age-related changes[6]:
The chronic, low-grade inflammation characteristic of aging brain[7]:
While both Aging-Related Microglia (ARM) and Disease-Associated Microglia (DAM) represent activated states, they differ[8]:
| Feature | ARM | DAM |
|---|---|---|
| Primary trigger | Aging | Neurodegeneration |
| TREM2 dependence | Partial | Required for Stage 2 |
| Spatial distribution | Throughout brain | Plaque/lesion-associated |
| Reversibility | Partially reversible | Variable |
| Disease-specific | No | Yes |
| Onset | Gradual with age | Acute in pathology |
Aging microglia show altered synaptic interactions[9]:
Age-related functional changes:
Reduced production of:
Aging microglia contribute to AD pathogenesis[10]:
In PD, aging microglia:
Minocycline: Anti-inflammatory in trials
Rapamycin: mTOR inhibition
Metformin: AMPK activation
Curcumin: NF-κB inhibition
Nicotinamide: SIRT1 activation
Microglial Polarization
Disease-Associated Microglia
Lipid-Loaded Microglia
TREM2 Microglial Pathway
Inflammasome and Neuroinflammation
Streit et al. Microglia and Alzheimer Disease pathogenesis (2004). 2004. ↩︎
Lowe et al. Microglia in aging and Alzheimer Disease (2019). 2019. ↩︎
Franceschi et al. Inflammaging: an evolutionary perspective (2018). 2018. ↩︎
Hammond et al. Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan (2019). 2019. ↩︎
Mrdjen et al. High-Dimensional Single-Cell Mapping of Central Nervous System Immune Cells (2018). 2018. ↩︎
López-Otín et al. The hallmarks of aging (2013). 2013. ↩︎
Franceschi et al. Inflammaging: chronic inflammation (2020). 2020. ↩︎
Deczkowska et al. Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration (2018). 2018. ↩︎
Baron et al. Microglia-mediated synapse loss in Alzheimer's Disease (2022). 2022. ↩︎
Wang et al. Role of pro-inflammatory cytokines in Alzheimer's Disease (2015). 2015. ↩︎